| Clinical, radiologic, pathologic, and molecular characteristics of long-term survivors of diffuse intrinsic pontine glioma (DIPG): a collaborative report from the International … LM Hoffman, SEM Veldhuijzen van Zanten, N Colditz, J Baugh, B Chaney, ... Journal of clinical oncology 36 (19), 1963-1972, 2018 | 342 | 2018 |
| Survival prediction model of children with diffuse intrinsic pontine glioma based on clinical and radiological criteria MH Jansen, SE Veldhuijzen van Zanten, E Sanchez Aliaga, ... Neuro-oncology 17 (1), 160-166, 2015 | 175 | 2015 |
| Molecular drug imaging: 89Zr-bevacizumab PET in children with diffuse intrinsic pontine glioma MH Jansen, SEMV van Zanten, DG Van Vuurden, MC Huisman, DJ Vugts, ... Journal of Nuclear Medicine 58 (5), 711-716, 2017 | 88 | 2017 |
| Development of the SIOPE DIPG network, registry and imaging repository: a collaborative effort to optimize research into a rare and lethal disease SEM Veldhuijzen van Zanten, J Baugh, B Chaney, D De Jongh, ... Journal of neuro-oncology 132, 255-266, 2017 | 64 | 2017 |
| Diagnostics and treatment of diffuse intrinsic pontine glioma: where do we stand? FE El-Khouly, SEM Veldhuijzen van Zanten, V Santa-Maria Lopez, ... Journal of neuro-oncology 145, 177-184, 2019 | 61 | 2019 |
| A twenty-year review of diagnosing and treating children with diffuse intrinsic pontine glioma in The Netherlands SEM Veldhuijzen van Zanten, MHA Jansen, E Sanchez Aliaga, ... Expert review of anticancer therapy 15 (2), 157-164, 2015 | 55 | 2015 |
| A small-molecule IAP inhibitor overcomes resistance to cytotoxic therapies in malignant gliomas in vitro and in vivo DS Ziegler, J Keating, S Kesari, EM Fast, L Zawel, N Ramakrishna, ... Neuro-oncology 13 (8), 820-829, 2011 | 43 | 2011 |
| A phase I/II study of gemcitabine during radiotherapy in children with newly diagnosed diffuse intrinsic pontine glioma SEM Veldhuijzen van Zanten, FE El-Khouly, MHA Jansen, DP Bakker, ... Journal of Neuro-oncology 135, 307-315, 2017 | 40 | 2017 |
| Effective drug delivery in diffuse intrinsic pontine glioma: a theoretical model to identify potential candidates FE El-Khouly, DG Van Vuurden, T Stroink, E Hulleman, GJL Kaspers, ... Frontiers in oncology 7, 254, 2017 | 37 | 2017 |
| The international diffuse intrinsic pontine glioma registry: an infrastructure to accelerate collaborative research for an orphan disease J Baugh, U Bartels, J Leach, B Jones, B Chaney, KE Warren, J Kirkendall, ... Journal of neuro-oncology 132 (2), 323-331, 2017 | 33 | 2017 |
| A suggestion to introduce the diagnosis of “diffuse midline glioma of the pons, H3 K27 wildtype (WHO grade IV)” AO von Bueren, M Karremann, GH Gielen, M Benesch, M Fouladi, ... Acta Neuropathologica 136, 171-173, 2018 | 31 | 2018 |
| External validation of the diffuse intrinsic pontine glioma survival prediction model: a collaborative report from the International DIPG Registry and the SIOPE DIPG Registry SEM Veldhuijzen van Zanten, A Lane, MW Heymans, J Baugh, B Chaney, ... Journal of neuro-oncology 134, 231-240, 2017 | 30 | 2017 |
| Palliative and end-of-life care for children with diffuse intrinsic pontine glioma: results from a London cohort study and international survey SEMV van Zanten, CLLI van Meerwijk, MHA Jansen, JWR Twisk, ... Neuro-oncology 18 (4), 582, 2016 | 30 | 2016 |
| State of affairs in use of steroids in diffuse intrinsic pontine glioma: an international survey and a review of the literature SEM Veldhuijzen van Zanten, O Cruz, GJL Kaspers, DR Hargrave, ... Journal of Neuro-oncology 128, 387-394, 2016 | 29 | 2016 |
| The added value of diagnostic and theranostic PET imaging for the treatment of CNS tumors IJ Pruis, GAMS van Dongen, SEM Veldhuijzen van Zanten International journal of molecular sciences 21 (3), 1029, 2020 | 28 | 2020 |
| Multiregional tumor drug-uptake imaging by PET and microvascular morphology in end-stage diffuse intrinsic pontine glioma SEMV van Zanten, ACP Sewing, A van Lingen, OS Hoekstra, P Wesseling, ... Journal of Nuclear Medicine 59 (4), 612-615, 2018 | 27 | 2018 |
| A phase I/II study of bevacizumab, irinotecan and erlotinib in children with progressive diffuse intrinsic pontine glioma FE El-Khouly, SEM Veldhuijzen van Zanten, MHA Jansen, DP Bakker, ... Journal of Neuro-oncology 153 (2), 263-271, 2021 | 24 | 2021 |
| Deceptive morphologic and epigenetic heterogeneity in diffuse intrinsic pontine glioma M Bugiani, SEMV van Zanten, V Caretti, P Schellen, E Aronica, DP Noske, ... Oncotarget 8 (36), 60447, 2017 | 23 | 2017 |
| FAPI PET versus FDG PET, CT or MRI for staging pancreatic-, gastric-and cholangiocarcinoma: systematic review and head-to-head comparisons of diagnostic performances SEM Veldhuijzen van Zanten, KJ Pieterman, BPL Wijnhoven, IJ Pruis, ... Diagnostics 12 (8), 1958, 2022 | 21 | 2022 |
| Noninvasive differentiation of molecular subtypes of adult nonenhancing glioma using MRI perfusion and diffusion parameters IJ Pruis, SR Koene, SR Van Der Voort, F Incekara, AJPE Vincent, ... Neuro-oncology advances 4 (1), vdac023, 2022 | 13 | 2022 |
